Document
IPR2024-00009, No. 1067 Exhibit - US Patent No 8,536,122 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1067 Exhibit - US Patent No 8,536,122 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1047 Exhibit - Tamimi, Drug Development, 13 NEPHRON CLINICAL PRACTICE c125 2009 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1047 Exhibit - Tamimi, Drug Development, 13 NEPHRON CLINICAL PRACTICE c125 2009 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1057 Exhibit - WO 2011073328 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1057 Exhibit - WO 2011073328 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1058 Exhibit - Blonde, Comparison of Liraglutidesuppl 2 DIABETES, OBES, METAB 2012 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1058 Exhibit - Blonde, Comparison of Liraglutidesuppl 2 DIABETES, OBES, METAB 2012 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1062 Exhibit - Zarin, The ClinicalTrialsgov Results Data, 364 NEW ENGL J MED 852 2011 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1062 Exhibit - Zarin, The ClinicalTrialsgov Results Data, 364 NEW ENGL J MED 852 2011 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1034 Exhibit - US Patent No 6,268,343 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1034 Exhibit - US Patent No 6,268,343 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1023 Exhibit - Drucker, Enhancing Incretin Action 26 DIABETES CARE 2929 2003 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1023 Exhibit - Drucker, Enhancing Incretin Action 26 DIABETES CARE 2929 2003 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00631, No. 1072 Exhibit - 1072 US Patent No 5,164,366 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1072 Exhibit - 1072 US Patent No 5,164,366 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1013 Exhibit - 1013 Clinical Trial No NCT00696657 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1013 Exhibit - 1013 Clinical Trial No NCT00696657 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1075 Exhibit - 1075 US Patent No 7,022,674 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1075 Exhibit - 1075 US Patent No 7,022,674 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1077 Exhibit - 1077 Award ClinicalTrialsgov, httpsashharvardedunewsclinicaltrials (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1077 Exhibit - 1077 Award ClinicalTrialsgov, httpsashharvardedunewsclinicaltrials (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1046 Exhibit - 1046 Yun, Pharmacokinetic and Pharmacodynamic Modelling of the Effects of G (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1046 Exhibit - 1046 Yun, Pharmacokinetic and Pharmacodynamic Modelling of the Effects of G (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1050 Exhibit - 1050 Garber, Efficacy of Metformin in Type II Diabetes Results of a Double (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1050 Exhibit - 1050 Garber, Efficacy of Metformin in Type II Diabetes Results of a Double (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1085 Exhibit - 1085 ACS Publications, httpspubsacsorgtocjmcmar4717 httpspubs (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1085 Exhibit - 1085 ACS Publications, httpspubsacsorgtocjmcmar4717 httpspubs (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1502 Exhibit - 1502 CV of Judith Korner, MD, PhD (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1502 Exhibit - 1502 CV of Judith Korner, MD, PhD (P.T.A.B. Mar. 1, 2024)
+ More Snippets